Clinical trial pipeline · Data from ClinicalTrials.gov
See which Metabolic Dysfunction Associated Steatohepatitis Mash Nonalcoholic Steatohepatitis Nash With Compensated Cirrhosis trials you may qualify forNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The study will assess the efficacy and safety of pegozafermin administered in participants with compensated cirrhosis due to MASH (biopsy-confirmed fibrosis sta…
This is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study in subjects with compensated cirrhosis due to NA…